Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Arthritis Rheumatol. 2017 Apr 4;69(6):1187–1193. doi: 10.1002/art.40047

Table 1. Anti-TNF therapy increases monocyte and granulocyte numbers in lymph nodes efferent to arthritic joints in TNF-Tg mice.

PLN from the TNF-Tg mice described in Figure 1 were harvested after 6-weeks of treatment, and analyzed by flow cytometry to quantify cells per PLN, which are presented as the mean ± SEM ×106 cells per PLN (* p<0.05 by unpaired t-test).

IgG treated Anti-TNF treated p-value
B cells (CD19+) 1.4 ± 0.3 2.4 ± 0.8 n.s.
T cells (CD3+) 0.5 ± 0.09 2.0 ± 0.7 n.s.
non-B/non-T (CD19, CD3) 1.8 ± 0.3 5.2 ± 1.0 0.009
monocytes/macrophages (CD3, CD19, CD11b+, CD11c, F4/80+) 0.8 ± 0.1 1.7 ± 0.4 0.047
granulocytes (CD3, CD19, CD11b+, CD11c, F4/80, Gr1+) 0.7 ± 0.09 2.0 ± 0.05 0.024